share_log

Roberts Wealth Advisors LLC Has $1.24 Million Position in Stericycle, Inc. (NASDAQ:SRCL)

Roberts Wealth Advisors LLC Has $1.24 Million Position in Stericycle, Inc. (NASDAQ:SRCL)

羅伯茨財富顧問公司在納斯達克公司持有124萬美元的股份。
Financial News Live ·  2022/09/18 12:21

Roberts Wealth Advisors LLC boosted its holdings in Stericycle, Inc. (NASDAQ:SRCL – Get Rating) by 2.9% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 27,852 shares of the business services provider's stock after buying an additional 775 shares during the period. Roberts Wealth Advisors LLC's holdings in Stericycle were worth $1,242,000 as of its most recent SEC filing.

根據羅伯茨財富顧問公司(Roberts Wealth Advisors LLC)向美國證券交易委員會(Securities and Exchange Commission,簡稱:美國證券交易委員會)披露的最新信息,該公司在第二季度增持了Stericycle,Inc.(代碼:SRCL-GET Rating)2.9%的股份。該公司持有這家商業服務提供商27,852股股票,在此期間又購買了775股。截至最近提交給美國證券交易委員會的文件,Roberts Wealth Advisors LLC持有的Stericycle股份價值1242,000美元。

Other large investors have also bought and sold shares of the company. Ancora Advisors LLC acquired a new position in Stericycle in the first quarter valued at approximately $34,000. Quent Capital LLC acquired a new position in Stericycle in the fourth quarter valued at approximately $33,000. Covestor Ltd acquired a new position in Stericycle in the fourth quarter valued at approximately $43,000. First Bank & Trust lifted its holdings in Stericycle by 13.4% in the first quarter. First Bank & Trust now owns 1,756 shares of the business services provider's stock valued at $103,000 after buying an additional 208 shares during the period. Finally, North Star Investment Management Corp. lifted its holdings in Stericycle by 38.5% in the first quarter. North Star Investment Management Corp. now owns 1,800 shares of the business services provider's stock valued at $106,000 after buying an additional 500 shares during the period. 98.05% of the stock is currently owned by institutional investors and hedge funds.

其他大型投資者也買賣了該公司的股票。Ancora Advisors LLC在第一季度收購了Stercycle的一個新頭寸,價值約3.4萬美元。Quent Capital LLC在第四季度收購了Stericycle的一個新頭寸,價值約為3.3萬美元。Covestor Ltd在第四季度收購了Stericycle的一個新頭寸,價值約為43,000美元。第一銀行和信託在第一季度增持了13.4%的Stericycle股份。First Bank&Trust現在持有這家商業服務提供商1,756股股票,價值10.3萬美元,在此期間又購買了208股。最後,北極星投資管理公司(North Star Investment Management Corp.)在第一季度增持了Stericycle 38.5%的股份。北極星投資管理公司現在持有這家商業服務提供商的1,800股股票,價值10.6萬美元,在此期間又購買了500股。該公司98.05%的股票目前由機構投資者和對衝基金持有。

Get
到達
Stericycle
腳踏車
alerts:
警報:

Stericycle Trading Down 2.1 %

自行車價格下跌2.1%

NASDAQ SRCL traded down $1.08 during trading hours on Friday, hitting $49.41. The company's stock had a trading volume of 1,063,632 shares, compared to its average volume of 307,531. Stericycle, Inc. has a twelve month low of $40.35 and a twelve month high of $70.91. The company has a quick ratio of 0.96, a current ratio of 0.96 and a debt-to-equity ratio of 0.71. The firm has a market capitalization of $4.55 billion, a P/E ratio of -52.01, a PEG ratio of 3.06 and a beta of 1.25. The stock has a fifty day moving average of $49.14 and a 200 day moving average of $50.31.

上週五交易時段,納斯達克股價下跌1.08美元,至49.41美元。該公司股票的成交量為1,063,632股,而其平均成交量為307,531股。Stercycle,Inc.的12個月低點為40.35美元,12個月高位為70.91美元。該公司的速動比率為0.96,流動比率為0.96,債務權益比率為0.71。該公司的市值為45.5億美元,市盈率為-52.01,聚乙二醇率為3.06,貝塔係數為1.25。該股的50日移動均線為49.14美元,200日移動均線為50.31美元。

Stericycle (NASDAQ:SRCL – Get Rating) last issued its earnings results on Friday, August 5th. The business services provider reported $0.48 EPS for the quarter, beating the consensus estimate of $0.44 by $0.04. Stericycle had a negative net margin of 3.28% and a positive return on equity of 6.22%. The firm had revenue of $679.80 million during the quarter, compared to the consensus estimate of $678.27 million. During the same quarter in the prior year, the firm earned $0.67 earnings per share. The business's quarterly revenue was up 1.1% on a year-over-year basis. Equities research analysts forecast that Stericycle, Inc. will post 2.02 earnings per share for the current fiscal year.
納斯達克(股票代碼:SRCL-GET Rating)最近一次發佈財報是在8月5日(週五)。這家商業服務提供商公佈本季度每股收益為0.48美元,比普遍預期的0.44美元高出0.04美元。Stercycle的淨利潤率為負3.28%,股本回報率為正6.22%。該公司本季度營收為6.798億美元,而市場普遍預期為6.7827億美元。去年同期,該公司每股收益為0.67美元。該業務的季度收入同比增長了1.1%。股票研究分析師預計,本財年Stericycle,Inc.的每股收益將達到2.02美元。

About Stericycle

關於四輪自行車

(Get Rating)

(獲取評級)

Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including sharps disposable and management solutions; pharmaceutical waste services; hazardous waste disposal; maritime waste services, such as seaport and airport waste; and compliance programs under the Steri-Safe, Clinical Services, First Practice Management, SeguriMed, and EnviroAssure brand names.

Stericycle,Inc.及其子公司在美國、歐洲和國際上提供監管和合規解決方案。該公司提供受監管的廢物和合規服務,包括Sharps一次性和管理解決方案;醫藥廢物服務;危險廢物處理;海運廢物服務,如海港和機場廢物;以及Steri-Safe、臨牀服務、First Practice Management、SeguriMed和EnviroAsure品牌下的合規計劃。

Further Reading

進一步閲讀

  • Get a free copy of the StockNews.com research report on Stericycle (SRCL)
  • Stock Market: 3 Islands Of Strength In A Sea Of Red
  • 3 Banks Worth Considering For Q4
  • MarketBeat: Week in Review 9/12 – 9/16
  • Is There a Cure for What is Ailing Teladoc Stock?
  • No One Told These 3 Stocks It's a Down Week
  • 免費獲取StockNews.com關於自行車的研究報告(SRCL)
  • 股市:紅海中的三座強國
  • 第四季度值得考慮的3家銀行
  • MarketBeat:回顧一週9/12-9/16
  • 有什麼辦法可以治癒Teladoc股票的問題嗎?
  • 沒有人告訴這三隻股票這是下跌的一週

Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle, Inc. (NASDAQ:SRCL – Get Rating).

想看看還有哪些對衝基金持有SRCL嗎?訪問HoldingsChannel.com以獲取Stericycle,Inc.(納斯達克代碼:SRCL-GET Rating)的最新13F備案文件和內幕交易信息。

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.

接受《腳踏車日報》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Stericycle和相關公司的最新新聞和分析師評級的每日簡明摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論